Trial sponsors say AI speeds timelines, but validation and governance lag
Surveys indicate that validation and governance gaps are holding back AI adoption in clinical trials. Sponsors acknowledge shorter timelines, but most say the technology has not yet lived up to expectations.
Who is affected and how
- pharmaceuticals
- Validation and governance processes for AI use in trials need strengthening before further rollout.
Sources
- AI Adoption in Clinical Trials Hindered by Validation, Governance Gapsthe clinical trial vanguard · Oct 12, 2026
- Drug Trial Sponsors Say AI Is Cutting Timelines — But Most Admit It Hasn’t Lived Up to the Hype Yet — Ai Data Newsaidatanews.com · Oct 12, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.